[Clinical experiences with a combination of Anabactyl and Varidase].
D000328:Adult; D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use*; D003668:Pressure Ulcer / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage*; D014946:Wound Infection / Q000188:drug therapy*
D000891:Anti-Infective Agents, Local; D010406:Penicillins; D013299:Streptodornase and Streptokinase; D002228:Carbenicillin
Klinische Erfahrungen mit einer Anabactyl-Varidase-Mischung.